Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
600
datasets available to search
ShareScore release 0.9.0
Dataset results
600 results for “Ophthalmitis”
Efficacy and Safety Study for Ecabet Ophthalmic Solution for Treating Dry Eye Syndrome
ClinicalTrials.gov study NCT00198536. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus
ClinicalTrials.gov study NCT07400952. IPD Sharing: NO. Countries: 1. Publications: 0.
Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy
ClinicalTrials.gov study NCT00442312. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease
ClinicalTrials.gov study NCT02665234. IPD Sharing: NO. Countries: 1. Publications: 0.
A Compassionate Case Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Glaucoma Patients With Uncontrolled Intraocular Pressure to Avoid Su
ClinicalTrials.gov study NCT02174991. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety Study of Squalamine Ophthalmic Solution in Subjects With Neovascular AMD
ClinicalTrials.gov study NCT02727881. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease
ClinicalTrials.gov study NCT06225973. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients
ClinicalTrials.gov study NCT01652664. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD)
ClinicalTrials.gov study NCT05376176. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AKB-9778 Ophthalmic Solution
ClinicalTrials.gov study NCT04284514. IPD Sharing: NO. Countries: 1. Publications: 0.
Ophthalmic Findings During 10-year Enzyme Substitution of Danish Fabry Patients.
ClinicalTrials.gov study NCT01997489. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®
ClinicalTrials.gov study NCT02028312. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Cornea
ClinicalTrials.gov study NCT01057147. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Corneal Endothelial Cell Density Changes, When Mapracorat Ophthalmic Suspension 3%, is Administered for 14 Days
ClinicalTrials.gov study NCT01736462. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Comparative Study of the Pharmacokinetic Profiles of Timolol Maleate Ophthalmic Gel With Timolol Maleate Gel
ClinicalTrials.gov study NCT06813807. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess the Effect of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Uncontrolled Advanced Glaucoma With Prior Failed Trabeculectomy or Tube Shunt
ClinicalTrials.gov study NCT02173223. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label, Long-Term Study With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic Conjunctivitis
ClinicalTrials.gov study NCT01037179. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Six-Week Safety Study of an Investigational Ophthalmic Solution
ClinicalTrials.gov study NCT01698814. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
ClinicalTrials.gov study NCT02179008. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessing the Atraumatic Technique in Ophthalmic Patients
ClinicalTrials.gov study NCT05572762. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.